DNA SEQUENCING - An Exclusive Market Insight Report Update

Thus it can be seen that pharmaceutical companies are working against high odds, so the need for streamlining and optimization of the recognition of new therapeutics is an extremely urgent matter.

Hyderabad, India (prHWY.com) May 8, 2012 - April 18, 2012 - RI Technologies' ( http://www.researchimpact.com/ ) report presents an in depth analysis of DNA Sequencing market. The study emphasizes on both, the Methods and Instruments/Software of DNA Sequencing in Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics application areas. Automated and Non-Automated (Sanger's, Maxam-Gilbert and Pyrosequencing) DNA Sequencing Methods are analyzed. The major Instruments/Software segments encompass Instruments (DNA Sequencers, DNA Synthesizers, DNA Sequencing Kits, and Microarray Technology) and Bio-Informatics. In depth Application analysis of Medical Research fields such as Proteomics, Pharmacogenomics and Molecular Diagnostics is also covered. The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information. The report lists more 500 companies that are engaged in DNA Sequencing services, instrumentation, R&D and supply of products and services. Major Contract Research Organizations serving the global DNA Sequencing industry are also covered in the corporate directory section of this report. Estimations and predictions are graphically represented by region, by technology and by product segment. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific, Japan and Rest of World. The market is analyzed in Dollars and includes 199 exclusive exhibits.

DNA is the carrier of genetic information in living organisms. It is said to be the blue print of an organism coordinating the various cellular activities and development. It regulates growth and metabolism and controls the traits, for example eye color. The order or sequence of the bases constitutes the specific instruction for a trait or activity. For example, the sequence ATCGTT may code for blue eye color and ATCGCT may express into brown eye color. But complex traits like intelligence appear to be influenced partly by inheritance and partly by environmental condition.

The introduction of DNA sequencing has extensively accelerated the pace of biological research and various discoveries. The quick pace of sequencing can easily be achieved by employing sophisticated modern DNA sequencing technology. This has enabled the large-scale sequencing of the human genome, which is part of the Human Genome Project. The numerous related projects by scientific collaboration have succeeded in generating the complete DNA sequences of for many plants, animals and microbial genomes across the globe.

The success of the human genome project has led to rapid advances in the life science industry. The life science industry in all aspects has received and will carry on receiving a tremendous amount of benefit from the human genome project. The entire range of processes from drug discovery to the progress and introduction of novel therapeutics are expected to contribute to this effect.

It is estimated that to develop a drug, an average investment of $1 billion has to be incurred. Out of the drugs that are presented for drug approval only 30% are able to break even. Thus it can be seen that pharmaceutical companies are working against high odds, so the need for streamlining and optimization of the recognition of new therapeutics is an extremely urgent matter. The solution to these problems lies in the profiling of pharmacogenomics. This will help in developing new medicines, which will be efficacious and will be able to achieve the desired result much faster. This will also augment the diagnostics for the developed drugs, which have already been positioned in the market. With an eye on these potential benefits pharmaceutical and biotechnology companies are keenly looking forward to the use of pharmacogenomics to help them identify compounds that have a profile of good safety and efficacy outlines. Pharmaceutical companies are realizing the importance of drug discovery procedures like DNA sequencing, which reduce time as well as cost of developing a product. In addition, they also verify the effectiveness of a drug.

DNA sequencing is showing promising results in treating pathogenic infections such as HIV and Hepatitis virus, as well as other ailments. However, it is gaining prominence because it offers a ray of hope for those afflicted with genetic disorders.

About RI Technologies

RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector with exclusive focus on product segments, global and regional market analysis, technology trends, industry outlook, competitor profiles, corporate directory and patents information. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The dedicated team works 24/7 to deliver unique reports that are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. The company's reports provide strategic information tools to the manufacturers, retailers, distributors, and suppliers that will help them to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. The strategic market information tables, graphically represented, will aid companies' research needs and help in forecasting, and gearing up to the future. Emphasis is on factual insights and forecasts with maximum global coverage. The company strives to provide market insight reports that empower customers with enlightening critical business information.

###

Tag Words: dna sequencing

Categories: Biotech

Press Release Contact
Customer Support: contactus@researchimpact.com. Call us at INDIA: +91 9676994272 / UK: 076-24-057837 for your biotechnology and healthcare market research report requirements. We provide 24/7 online a

Link To This Press Release:

URL HTML Code